Company: VCYT
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001384101-25-000130
Chunk: 16

Company: VERACYTE, INC.
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 1
Chunk 16
---
ESPP)72 — 1,405 — — 1,405 Tax portion of vested restricted stock units— — (2,814)— — (2,814)Stock-based compensation expense (employee)— — 10,398 — — 10,398 Stock-based compensation expense (ESPP)— — 359 — — 359 Net income— — — 19,137 — 19,137 Currency translation adjustments— — — — (4,556)(4,556)Release of accumulated translation adjustment— — — — 8,295 8,295 Balance at September 30, 202579,034 $79 $1,684,587 $(418,779)$(8,220)$1,257,667 Balance at December 31, 202477,773 $78 $1,655,961 $(443,983)$(36,090)$1,175,966 Issuance of common stock upon exercise of stock options and vesting of restricted stock units1,105 1 7,519 — — 7,520 Issuance of common stock under ESPP156 — 3,052 — — 3,052 Tax portion of vested restricted stock units— — (14,645)— — (14,645)Stock-based compensation expense (employee)— — 31,866 — — 31,866 Stock-based compensation expense (ESPP)— — 834 — — 834 Net income— — — 25,204 — 25,204 Currency translation adjustments— — — — 19,575 19,575 Release of accumulated translation adjustment— — — — 8,295 8,295 Balance at September 30, 202579,034 $79 $1,684,587 $(418,779)$(8,220)$1,257,667 

4

 Common StockAdditionalPaid-inCapitalAccumulated DeficitAccumulated Other Comprehensive LossTotalStockholders'Equity SharesAmountBalance at June 30, 202476,744 $77 $1,627,307 $(464,251)$(30,610)$1,132,523 Issuance